ftInvstr
VALIANTLAB · Healthcare ₹105.97 +4.99% Mkt Cap ₹576 Cr

VALIANTLAB

Healthcare Drug Manufacturers - Specialty & Generic
₹105.97
+4.99% today · 30d +70.92%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for VALIANTLAB. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹115 Cr
+146.22% YoY
NET PROFIT
₹21 Cr
+1058.93% YoY
OPM
25.93%
+19.5pp YoY
EPS
₹3.89
PE 36.72
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-7.7% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
VALIANTLAB36.721.0
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
70
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 90
Valuation FAIR 40
Growth STRONG 70
Profitability DECENT 60
Technicals NEUTRAL 68
Risk LOW 90
Key Stats
TTM PE
36.72
P/B
1.92
52W HIGH
₹110.7
OFF HIGH
-4.27%
MKT CAP
₹576 Cr
◉ Active Signals
MACDBullish0.0104
RSI(14)Bearish71.15
Near 52W HighBullish-4.27
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold VALIANTLAB and at what entry.

Sign up freeSign in